• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center.

作者信息

Saini Nitin, Bhagat Ashish, Sharma Sanjeev, Duseja Ajay, Chawla Yogesh

机构信息

Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

Clin Chim Acta. 2006 Sep;371(1-2):183-6. doi: 10.1016/j.cca.2006.02.038. Epub 2006 May 2.

DOI:10.1016/j.cca.2006.02.038
PMID:16647699
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver. Several etiologic factors including hepatitis viruses, alcohol and aflatoxin have been implicated in the pathogenesis of HCC. However, there is limited information regarding clinicopathological profile of HCC from the Indian subcontinent.

METHODS

Forty seven patients of HCC (M=43, F=4) diagnosed on the basis of history, clinical examination, imaging (USG, CT/MRI), alpha-fetoprotein (AFP) and by USG/CT guided FNAC, were included. Patients were screened for HBV, HCV and history of alcohol. Tumor size was assessed on imaging and UGI endoscopy for the presence of varices.

RESULTS

The mean age was 53.4+/-14.6 y. Clinical presentation included anorexia in 32 (68%), abdominal pain in 28 (60%), loss of weight in 23 (49%), fever in 12 (26%), and jaundice in 6 (13%) patients. Twenty nine (62%) had underlying cirrhosis, diagnosed by ultrasound or CT. Seventeen percent had normal AFP (<10 ng/ml) and the remaining 83% had raised AFP [<10 ng/ml=7, 10-400 ng/ml=27, >400 ng/ml=8]. Thirteen patients (28%) were consuming alcohol in cirrhogenic doses and 10 (21%) were smokers. Fifty four percent were positive for HBsAg, 47% of these were also positive for HBeAg. Twenty seven percent were positive for anti-HCV. Tumor size on imaging was analyzed in 33 patients. Tumor size varied from <3 cm in 8 (18%), 3-5 cm in 12 (27%) and >5 cm in 25 (56%) patients. Twenty-three patients were lost to follow-up, 4 died and 6 did not agree for any treatment. Only 5 patients could be subjected to hepatic resection. Remaining 9 patients had a large tumor size and were put on tamoxifen.

CONCLUSION

More than half of the HCC cases have underlying cirrhosis. Hepatitis B virus infection is commonly associated. Most of patients have a large tumor (>5 cm) at presentation.

摘要

相似文献

1
Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center.
Clin Chim Acta. 2006 Sep;371(1-2):183-6. doi: 10.1016/j.cca.2006.02.038. Epub 2006 May 2.
2
Hepatocellular carcinoma: analysis of 76 cases.肝细胞癌:76例病例分析。
J Pak Med Assoc. 1998 Jul;48(7):197-201.
3
Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.甲胎蛋白作为肝细胞癌的肿瘤标志物:对南印度感染嗜肝病毒和黄曲霉毒素致病的受试者的研究
Int J Infect Dis. 2008 Nov;12(6):e71-6. doi: 10.1016/j.ijid.2008.04.010. Epub 2008 Jul 26.
4
Natural history of chronic hepatitis B REVEALed.慢性乙型肝炎的自然史被揭示。
J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x.
5
[Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis].[HBsAg 阳性肝硬化患者发生肝细胞癌过程中血清甲胎蛋白水平短暂升高的临床意义]
Korean J Gastroenterol. 2004 Apr;43(4):252-9.
6
Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.隐匿性乙型肝炎病毒感染和既往乙型肝炎病毒感染对丙型肝炎病毒所致肝硬化患者肝细胞癌发生的影响
Scand J Gastroenterol. 2008;43(7):849-56. doi: 10.1080/00365520801935459.
7
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.慢性肝炎、肝硬化和肝细胞癌患者的去γ-羧基凝血酶原、甲胎蛋白和甲胎蛋白-L3
J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.
8
Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients.比利时肝细胞癌:154例连续性肝硬化和非肝硬化患者的临床及病毒学特征
Eur J Gastroenterol Hepatol. 2000 Jan;12(1):61-6.
9
The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.血清甲胎蛋白水平在抗丙型肝炎病毒阳性患者中筛查肝细胞癌的有效性。
Hepatogastroenterology. 1999 Nov-Dec;46(30):3208-11.
10
Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.肝细胞癌的临床细胞病理学谱、其与血清甲胎蛋白水平的相关性以及乙型和丙型肝炎病毒标志物
Trop Gastroenterol. 2004 Jul-Sep;25(3):116-20.

引用本文的文献

1
Changing Etiological Spectrum of Hepatocellular Carcinoma in India-A Systematic Review and Meta-analysis.印度肝细胞癌病因谱的变化——一项系统评价与荟萃分析
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101391. doi: 10.1016/j.jceh.2024.101391. Epub 2024 Mar 4.
2
Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study.印度伴有和不伴有肝硬化背景的肝细胞癌患者的病因分数:一项多中心研究。
Hepatol Int. 2023 Jun;17(3):745-752. doi: 10.1007/s12072-023-10498-w. Epub 2023 Mar 20.
3
Serum MicroRNAs as Predictors for HCV Progression and Response to Treatment in Pakistani Patients.
血清 microRNAs 作为巴基斯坦患者 HCV 进展和治疗反应的预测因子。
Genes (Basel). 2023 Feb 9;14(2):441. doi: 10.3390/genes14020441.
4
Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India.肝细胞癌患者特征:印度一家三级护理中心的经验。
Indian J Gastroenterol. 2022 Apr;41(2):127-134. doi: 10.1007/s12664-021-01209-0. Epub 2022 Feb 28.
5
Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.现实环境中肝细胞癌病因变化及非移植性根治性治疗方式的经验——一项回顾性描述性分析
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):682-690. doi: 10.1016/j.jceh.2021.02.002. Epub 2021 Feb 11.
6
Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients.磷脂酰肌醇蛋白聚糖-3在肝硬化患者肝细胞癌早期检测中的意义
J Gastrointest Cancer. 2019 Sep;50(3):434-441. doi: 10.1007/s12029-018-0095-2.
7
Current Scenario of Hepatitis B and Its Treatment in India.印度乙型肝炎的现状及其治疗
J Clin Transl Hepatol. 2017 Sep 28;5(3):277-296. doi: 10.14218/JCTH.2017.00024. Epub 2017 Jul 8.
8
Current profile of hepatocellular carcinoma from a tertiary care center in Andhra Pradesh.来自安得拉邦一家三级医疗中心的肝细胞癌现状
Indian J Gastroenterol. 2015 Jul;34(4):335-6. doi: 10.1007/s12664-015-0590-3.
9
The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.印度肝脏研究国家协会(INASL)关于印度肝细胞癌预防、诊断和管理的共识:普里建议
J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S3-S26. doi: 10.1016/j.jceh.2014.04.003. Epub 2014 May 22.
10
Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India.印度北部旁遮普邦一家三级护理医院的肝细胞癌概况。
Indian J Gastroenterol. 2014 Jan;33(1):35-40. doi: 10.1007/s12664-013-0373-7. Epub 2013 Sep 6.